Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma

PURPOSE: Prognostic models for pleural mesothelioma (MPM) are needed to prevent potentially futile outcomes. We combined MPM plasma biomarkers with validated clinical prognostic indices to determine whether stratification of risk for death in 194 MPM patients improved. PATIENTS AND METHODS: Individu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Oncol
Hlavní autoři: Pass, Harvey I., Goparaju, Chandra, Espin-Garcia, Osvaldo, Donington, Jessica, Carbone, Michele, Patel, Devalben, Chen, Zhuo, Feld, Ronald, Cho, John, Gadgeel, Shirish, Wozniak, Antoinette, Chachoua, Abraham, Leighl, Natasha, Tsao, Ming-Sound, de Perrot, Marc, Xu, Wei, Liu, Geoffrey
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5978729/
https://ncbi.nlm.nih.gov/pubmed/26903362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2016.02.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky